• LAST PRICE
    0.0380
  • TODAY'S CHANGE (%)
    Trending Down-0.0005 (-1.2987%)
  • Bid / Lots
    0.0360/ 200
  • Ask / Lots
    0.0389/ 200
  • Open / Previous Close
    0.0370 / 0.0385
  • Day Range
    Low 0.0360
    High 0.0415
  • 52 Week Range
    Low 0.0335
    High 0.5400
  • Volume
    388,739
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.0385
TimeVolumeBGXX
09:32 ET94440.038
09:34 ET1000.0385
09:38 ET2575790.038
09:43 ET19240.036
09:54 ET480040.0379
09:56 ET400000.03797
10:01 ET100000.038
10:08 ET211710.038
10:12 ET1630.038
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBGXX
Bright Green Corp
37.8M
-0.7x
---
United StatesEYEN
Eyenovia Inc
41.3M
-0.7x
---
United StatesKALA
KALA BIO Inc
27.2M
-0.4x
---
United StatesODTC
Odonate Inc
49.9M
-1,258.5x
---
United StatesPYPD
PolyPid Ltd
24.4M
-0.4x
---
United StatesACST
Acasti Pharma Inc
23.2M
-2.6x
---
As of 2024-09-30

Company Information

Bright Green Corporation is a producer and manufacturer of plant-based drugs and active pharmaceutical ingredients (APIs). The Company specializes in the research, production, distribution, and advancement of plant-based drugs and APIs, including psilocybin, psilocyn, peyote, and opium poppy. It plans to focus on the development of cannabis strains and sales of cannabis and hemp products with high contents of cannabinol (CBN) and cannabigerol (CBG). It also plans to cultivate cannabis and focus on the production of dried flowers, and oils and marijuana extracts. In addition to cannabis, it also has a separate area for controlled substance cactus cultivation, and a separate controlled area for mushroom propagation. It is in the process of completing construction of the 22-acre existing greenhouse to comply with the requirements for Schedule I and Schedule II plant-based drugs. It also plans to construct two new 57-acre greenhouses, one each on the Candelaria property and Azuz property.

Contact Information

Headquarters
401 East Las Olas Blvd., Suite 1400FT LAUDERDALE, FL, United States 33301
Phone
201-370-1140
Fax
302-636-5454

Executives

Chairman of the Board
Lynn Stockwell
Chief Executive Officer, Director
Gurvinder Singh
Chief Financial Officer
Saleem Elmasri
Lead Independent Director
Dean Valore
Independent Director
Robert Arnone

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$37.8M
Revenue (TTM)
$0.00
Shares Outstanding
190.2M
Bright Green Corp does not pay a dividend.
Beta
---
EPS
$-0.05
Book Value
$0.06
P/E Ratio
-0.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.